文献速递免疫规划传染病防控与疫情报告

2012年柳州市3~23月龄儿童流行性脑脊髓膜炎保护率及抗体水平分析

[Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2016-01-01

2012年5月至8月在柳州市柳江、融安、三江三县便利抽样调查603名3~23月龄儿童,采用血清杀菌试验检测A群和C群脑膜炎奈瑟菌抗体。A群抗体GMT为1∶1.11,阳性率7.6%,保护率2.0%;C群GMT为1∶1.18,阳性率14.6%,保护率2.2%。结论认为该年龄组对A群和C群易感,A群多糖疫苗免疫效果较差且抗体水平下降快。

要点

  • 3~23月龄儿童A群脑膜炎奈瑟菌抗体GMT为1∶1.11,保护率仅2.0%。
  • C群脑膜炎奈瑟菌抗体GMT为1∶1.18,阳性率14.6%,保护率2.2%。
  • 接种1剂与2剂A群疫苗儿童抗体GMT和保护率差异均无统计学意义。

核心结论

  • 3~23月龄儿童对A群和C群脑膜炎奈瑟菌均易感,A群脑膜炎球菌多糖疫苗在该年龄组免疫效果较差且抗体水平下降快。

研究设计与样本

  • 2012年5月至8月在柳州市柳江、融安、三江三县采用便利抽样,纳入603名3~23月龄、无流脑病史、未接种C群脑膜炎奈瑟菌疫苗且距末次A群疫苗接种超过30天的儿童。
  • 采用问卷调查获取人口学信息和免疫史,采集静脉血2.0 ml,用血清杀菌试验检测脑膜炎奈瑟菌抗体水平。

主要发现

  • 603名儿童中女325名(53.9%)、男278名(46.1%);未接种、接种1剂和接种2剂疫苗者分别为276名(45.8%)、143名(23.7%)和184名(30.5%)。
  • A群脑膜炎奈瑟菌血清抗体GMT为1∶1.11,阳性率7.6%(46名),保护率2.0%(12名)。
  • 接种1剂疫苗儿童A群抗体GMT为1∶1.16、保护率3.5%(5名),接种2剂疫苗儿童GMT为1∶1.2、保护率3.5%(5名),差异均无统计学意义(GMT:H=0.64,P=0.728;保护率:Fisher精确检验,P=0.080)。
  • 接种1剂和2剂脑膜炎球菌多糖疫苗儿童抗体GMT分别为1∶1.12和1∶2.30(≤180 d)。
  • C群脑膜炎奈瑟菌血清抗体GMT为1∶1.18,阳性率14.6%(88名),保护率2.2%(13名)。

关键数值与推荐

  • 血清杀菌试验抗体GMT≥1∶2为阳性,>1∶8为具有保护性。
  • A群抗体GMT 1∶1.11,阳性率7.6%(46名),保护率2.0%(12名)。
  • C群抗体GMT 1∶1.18,阳性率14.6%(88名),保护率2.2%(13名)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To understand the level of bactericidal antibodies against Neisseria meningitidis and their rate of protection in children aged between 3 and 23 months, in Liuzhou, in 2012. Methods: Convenience sampling was performed in Liujiang, Rong'an and Sanjiang Counties from May through August, 2012. The inclusion criteria for 603 subjects were: Children aged between 3 and 23 months; no history of meningococcal meningitis; no vaccination against Neisseria meningitidis serogroup C; more than 30 days from the last vaccination against Neisseria meningitidis serogroup A. Demographic information and immunization history of the subjects were obtained using questionnaires. Venous blood samples (2.0 ml each) were collected and levels of Neisseria meningitides antibodies determined using a Serum Bactericidal Assay (SBA). The geometric mean titer (GMT) of serum bacterial antibodies was positive when it was greater than or equal to 1∶2 and protective when greater than 1∶8. Chi-square and Fisher's exact tests were used to compare differences in the positive and protective rates of serum antibodies of Neisseria meningitidis serogroup A and Neisseria meningitidis serogroup C, among children with different demographic characteristics. Kruskal-Wallis H test was used to compare differences in the GMT of serum antibodies of Neisseria meningitidis serogroup A and Neisseria meningitidis serogroup C, among children with different demographic characteristics. Results: Of 603 subjects, 325 (53.9%) were female and 278 (46.1%) were male; 276 (45.8%), 143 (23.7%) and 184 (30.5%) subjects were administered, respectively, no treatment, 1 dose vaccine and 2 doses vaccine. The GMT of serum antibodies against group A Neisseria meningitidis was 1∶1.11, the positive rate was 7.6% (46) and the protective rate was 2.0% (12). The GMT of antibodies in children receiving 1 vaccine dose was 1∶1.16 and the protective rate was 3.5% (5), both values higher than those in children receiving 2 vaccine doses (GMT: 1∶1.2, protective rate: 3.5% (5)). However, these differences were not statistically significant (GMT: H=0.64, P=0.728; protective rate: Fisher's exact test, P= 0.080). The GMT of antibodies in children receiving 1 and 2 doses of meningococcal polysaccharide vaccines were 1∶1.12 and 1∶2.30, respectively (≤180 d). The GMT of serum antibodies for group C meningococcal vaccine was 1∶1.18 and its positive and protective rates were 14.6% (88) and 2.2% (13), respectively. Conclusion: Children aged between 3 and 23 months are susceptible to Neisseria meningitidis groups A and C. The immune effectiveness of group A meningococcal polysaccharide vaccine is relatively poor in this age group and their antibody levels decreased rapidly.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cui XL, Wu X, Li MQ, et al. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012]. Zhonghua Yu Fang Yi Xue Za Zhi. 2016. PMID: 28057112. doi:10.3760/cma.j.issn.0253-9624.2016.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。